- The Roche Digital Pathology Open Environment brings together a wide array of innovative AI-based pathology tools to help clinicians improve patient care and expand personalised healthcare.
- Roche is now integrating more than 20 artificial intelligence (AI) algorithms from eight new collaborators into its digital pathology open environment.
- AI technology helps enhance pathology with high value insights, which can benefit cancer patients through precision medicine leading to targeted treatment.
TUCSON, Ariz., Sept. 9, 2024 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the expansion of its digital pathology open environment with the integration of more than 20 advanced artificial intelligence (AI) algorithms from eight new collaborators. These strategic collaborations aim to support pathologists and scientists in cancer research and diagnosis by leveraging cutting-edge AI technology.
The seamless integration is facilitated through Roche’s navify®Digital Pathology enterprise software, an application …